The Clinical Research Directed Initiative (CRDI) is a competitive internal funding mechanism designed to support physician-led, hypothesis-driven clinical and translational research. The program aims to accelerate the development of impactful projects that will lead to competitive extramural funding. Proposals must be supported by preliminary data and designed to generate data to directly support extramural grant submission.
Budget
$100,000 over 12 months
Eligibility
A) Principal Investigator(s): Faculty at all academic ranks. At least one PI must be a physician with extramural funding.
B) Co-Investigator: Must include at least one fellow/resident/postdoc.
C) Student Participation: Inclusion of at least one student is required.
2026 Key Dates
April 15, 2026 | RFA Release |
May 27, 2026 | Application Deadline |
Late June 2026 | CRDI Committee Review |
July 2026 | Awardees Notified |
September 1, 2026 | Program Start Date |
2026 CRDI RFA
Applications are reviewed by the CRDI Review Committee and decisions receive final approval from the Office of the CRO.
CRDI Review Committee
Committee Chair: Randall Urban, MD
Primary Reviewers: UTMB Grant Review & Oversight (GRO) committee members
Secondary Reviewers: CTSA alliance members (Houston Methodist, Texas Southern University, University of Houston-Clear Lake)